Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D006220:Haloperidol / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013134:Spiperone / Q000378:metabolism; D019805:alpha-Methyltyrosine
D008781:Methyltyrosines; D011954:Receptors, Dopamine; D007980:Levodopa; D013134:Spiperone; D019805:alpha-Methyltyrosine; D006220:Haloperidol; D004298:Dopamine